Breaking News Instant updates and real-time market news.

OPNT

Opiant Pharmaceuticals

$22.55

-0.35 (-1.53%)

16:57
09/14/18
09/14
16:57
09/14/18
16:57

Valour Fund reports 5.4% passive stake in Opiant Pharmaceuticals

  • 01

    Oct

OPNT Opiant Pharmaceuticals
$22.55

-0.35 (-1.53%)

06/11/18
CANT
06/11/18
INITIATION
Target $32
CANT
Overweight
Opiant Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald
Cantor initiated Opiant Pharmaceuticals with an Overweight and $32 price target.
06/12/18
CANT
06/12/18
INITIATION
CANT
Cantor expands Specialty Pharmaceuticals coverage with eight names
Cantor Fitzgerald analyst Brandon Folkes last night rolled out coverage on eight names in the Specialty Pharmaceuticals space. He initiated coverage of AcelRx (ACRX), ANI Pharmaceuticals (ANIP), Biohaven Pharmaceutical (BHVN), Collegium Pharmaceutical (COLL), Emergent BioSolutions (EBS), Eagle Pharmaceuticals (EGRX) and Opiant Pharmaceuticals (OPNT) with Overweight ratings. There is still value to be unlocked in these stocks at current valuations with risk/reward profiles that remain to the upside, Folkes told investors in a research note. His top picks are ANI Pharmaceuticals, Emergent BioSolutions and Collegium Pharmaceutical. The analyst rounded out his coverage with a Neutral rating on Momenta (MNTA), saying the recent share rally puts him on the sidelines "for now."
08/10/18
CANT
08/10/18
NO CHANGE
Target $32
CANT
Overweight
Cantor reiterates Overweight on Opiant ahead of pipeline readouts
Cantor Fitzgerald analyst Brandon Folkes reiterates an Overweight rating on Opiant Pharmaceuticals with a $32 price target following the company's Q2 results. The analyst expect investors to begin to appreciate the market potential of Opiant's pipeline, "which should drive the stock higher." The company is developing treatments focused on multiple addictions as well a new product for opioid overdose, Folkes tells investors in a research note titled "Pipeline Readouts in '18 and '19 Make Us Even More Positive on OPNT Stock."
08/29/18
CANT
08/29/18
NO CHANGE
Target $32
CANT
Overweight
Cantor sees value in Opiant after Emergent acquires Adapt Pharma
Cantor Fitzgerald analyst Brandon Folkes believes Emergent BioSolutions' (EBS) acquisition of Adapt Pharma underscores the potential for companies addressing the opioid overdose market. Opiant Pharmaceuticals (OPNT) is developing its own opioid overdose nasal spray, OPNT003, which could be of benefit in cases of synthetic opioid overdoses, such as with fentanyl, Folkes tells investors in a research note. He believes Opiant presents an attractive risk/reward at current share levels, "even if it captures only a portion of the growing market opioid overdose market." Folkes keeps an Overweight rating on the shares with a $32 price target.

TODAY'S FREE FLY STORIES

GLNG

Golar LNG

$21.21

-0.75 (-3.42%)

13:45
01/23/19
01/23
13:45
01/23/19
13:45
Options
Golar LNG call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$31.16

-1.1 (-3.41%)

, SQ

Square

$68.86

1.16 (1.71%)

13:41
01/23/19
01/23
13:41
01/23/19
13:41
Periodicals
Twitter CEO tells Rolling Stone work on abuse 'needs to be done' »

Twitter (TWTR) and Square…

TWTR

Twitter

$31.16

-1.1 (-3.41%)

SQ

Square

$68.86

1.16 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 07

    Feb

  • 25

    Feb

  • 03

    Mar

CTGO

Contango Ore

$0.00

(0.00%)

13:32
01/23/19
01/23
13:32
01/23/19
13:32
Hot Stocks
Contango Ore starts process to solicit proposals for potential sale »

Contango ORE announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETFC

E-Trade

$49.05

-1.03 (-2.06%)

13:30
01/23/19
01/23
13:30
01/23/19
13:30
Options
Active trading in ETrade weekly options as shares fall ahead of earnings »

Active trading in ETrade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 11

    Feb

AG

First Majestic

$5.25

0.08 (1.55%)

13:25
01/23/19
01/23
13:25
01/23/19
13:25
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:20
01/23/19
01/23
13:20
01/23/19
13:20
General news
U.S. corporate bond update: ADB's $3.5 B 5-year headlines today »

U.S. corporate bond…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
01/23/19
01/23
13:17
01/23/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
01/23/19
01/23
13:16
01/23/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCL

Royal Caribbean

$107.77

-0.84 (-0.77%)

13:15
01/23/19
01/23
13:15
01/23/19
13:15
Options
Royal Caribbean put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBHT

J.B. Hunt

$101.72

-2.03 (-1.96%)

13:12
01/23/19
01/23
13:12
01/23/19
13:12
Hot Stocks
J.B. Hunt raises quarterly dividend approx. 8.3% to 26c per share »

J.B. Hunt Transport…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:10
01/23/19
01/23
13:10
01/23/19
13:10
General news
Treasury Option Action: flows remain at low ebb »

Treasury Option Action:…

NTDOY

Nintendo

$0.00

(0.00%)

, TTWO

Take-Two

$101.62

-5.62 (-5.24%)

13:09
01/23/19
01/23
13:09
01/23/19
13:09
Periodicals
NPD says 'Smash Bros.' best-selling game in December in U.S., GI reports »

According to NDP Group,…

NTDOY

Nintendo

$0.00

(0.00%)

TTWO

Take-Two

$101.62

-5.62 (-5.24%)

ATVI

Activision Blizzard

$45.97

-1.07 (-2.27%)

EA

Electronic Arts

$89.46

-1.84 (-2.02%)

SNE

Sony

$48.27

-0.185 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 05

    Feb

  • 06

    Feb

  • 12

    Feb

  • 25

    Feb

WBA

Walgreens Boots Alliance

$71.40

-0.19 (-0.27%)

13:07
01/23/19
01/23
13:07
01/23/19
13:07
Recommendations
Walgreens Boots Alliance analyst commentary  »

Walgreens already…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

TSLA

Tesla

$284.24

-14.56 (-4.87%)

13:04
01/23/19
01/23
13:04
01/23/19
13:04
Periodicals
Tesla scaled down Model S and X staff in recent layoffs, CNBC says »

According to a CNBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

KCAP

KCAP Financial

$3.51

-0.05 (-1.40%)

13:01
01/23/19
01/23
13:01
01/23/19
13:01
Hot Stocks
Private Management Group reports 6.59% passive stake in KCAP Financial »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIGO

Millicom

$62.07

-7.03 (-10.17%)

13:00
01/23/19
01/23
13:00
01/23/19
13:00
Hot Stocks
Gabelli says 'gotta buy' Millicom on today's selloff »

Mario Gabelli is speaking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$261.89

-1.165 (-0.44%)

13:00
01/23/19
01/23
13:00
01/23/19
13:00
Hot Stocks
Trump says will deliver SOTU address next week in House Chamber »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$261.89

-1.165 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTZ

MasTec

$43.51

-2.08 (-4.56%)

13:00
01/23/19
01/23
13:00
01/23/19
13:00
Options
Defensive option play in MasTec as shares drop almost 5% »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVNA

Carvana

$36.10

0.46 (1.29%)

, AN

AutoNation

$36.08

-0.96 (-2.59%)

12:58
01/23/19
01/23
12:58
01/23/19
12:58
Hot Stocks
Gabelli mentions Carvana, AutoNation as stock picks »

Mario Gabelli is speaking…

CVNA

Carvana

$36.10

0.46 (1.29%)

AN

AutoNation

$36.08

-0.96 (-2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 29

    Jan

  • 22

    Feb

  • 27

    Feb

  • 27

    Feb

F

Ford

$8.32

-0.19 (-2.23%)

, GM

General Motors

$37.69

-0.49 (-1.28%)

12:58
01/23/19
01/23
12:58
01/23/19
12:58
Earnings
Fly Intel: What to watch in auto sector earnings reports »

Ford (F) is scheduled to…

F

Ford

$8.32

-0.19 (-2.23%)

GM

General Motors

$37.69

-0.49 (-1.28%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 06

    Feb

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

GFF

Griffon

$12.99

-0.185 (-1.40%)

12:54
01/23/19
01/23
12:54
01/23/19
12:54
Hot Stocks
Breaking Hot Stocks news story on Griffon »

Griffon jumps 5% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$88.06

-0.2 (-0.23%)

12:53
01/23/19
01/23
12:53
01/23/19
12:53
Periodicals
Novartis preparing for 'doomsday' scenario in cancer treatment, BI reports »

Novartis is preparing for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSG

Madison Square Garden

$271.84

-2.105 (-0.77%)

12:52
01/23/19
01/23
12:52
01/23/19
12:52
Hot Stocks
Madison Square Garden shares could be worth as much as $350, Gabelli says »

Mario Gabelli is speaking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

GFF

Griffon

$13.01

-0.165 (-1.25%)

, ENR

Energizer

$45.35

0.07 (0.15%)

12:51
01/23/19
01/23
12:51
01/23/19
12:51
Hot Stocks
Griffon, Energizer mentioned as stock picks by Mario Gabelli »

Mario Gabelli is speaking…

GFF

Griffon

$13.01

-0.165 (-1.25%)

ENR

Energizer

$45.35

0.07 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

CVE

Cenovus Energy

$7.53

-0.21 (-2.71%)

12:50
01/23/19
01/23
12:50
01/23/19
12:50
Options
Cenovus Energy call buyers adding to positions opened yesterday »

Cenovus Energy call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.